PET Pronostic Biomarkers Exploratory Analyses About Initial FDG-PET In Patients With Anal Carcinoma

被引：0
|
作者：
Testard, A. [1 ]
Le Thiec, M. [2 ]
Ferrer, L. [3 ,4 ]
Guillerminet, C. [5 ]
Morel, O. [1 ]
Kraeber-Bodere, F. [2 ,4 ]
Rousseau, C. [2 ,4 ]
机构：
[1] ICO Canc Ctr, Nucl Med Unit, Angers, France
[2] ICO Canc Ctr, Nucl Med Unit, St Herblain, France
[3] ICO Canc Ctr, Phys Unit, St Herblain, France
[4] Univ Nantes, INSERM, UMR1232, CRCINA,CNRS,ERL6001, Nantes, France
[5] ICO Canc Ctr, Phys Unit, Angers, France
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2018年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0431
引用
收藏
页码：S466 / S466
页数：1
相关论文
共 50 条
  • [1] Prognostic value of initial and post-chemoradiotherapy FDG-PET in patients with anal carcinoma
    Testard, A.
    Guillerminet, C.
    Campion, L.
    Lacombe, M.
    Girault, S.
    Morel, O.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S279 - S279
  • [2] FDG-PET/CT in the evaluation of anal carcinoma
    Cotter, Shane E.
    Grigsby, Perry W.
    Siegel, Barry A.
    Dehdashti, Farrokh
    Malyapa, Robert S.
    Fleshman, James W.
    Birnbaum, Elisa H.
    Wang, Xia
    Abbey, Elliot
    Tan, Benjamin
    Kodner, Ira J.
    Hunt, Steven R.
    Lowney, Jennifer K.
    Mutch, Matthew G.
    Dietz, David W.
    Myerson, Robert J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 65 (03): : 720 - 725
  • [3] FDG-PET for Staging, Surveillance, and Prognostication in Anal Canal Carcinoma
    Duimering, A.
    Riauka, T.
    McEwan, A.
    Ghosh, S.
    Nijjar, Y.
    Jacobs, J.
    Reif, R.
    Nijjar, T.
    Severin, D. M.
    Tankel, K.
    Usmani, N. H.
    Fairchild, A. M.
    MacEwan, R.
    Hudson, E.
    Wong, C.
    Schiller, D.
    Mulder, K.
    Doll, C. M.
    Joseph, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E144 - E145
  • [4] FDG-PET and hepatocellular carcinoma
    Toru Kashiwagi
    Journal of Gastroenterology, 2004, 39 : 1017 - 1018
  • [5] FDG-PET in adrenocortical carcinoma
    Becherer, A
    Vierhapper, H
    Pötzi, C
    Karanikas, G
    Kurtaran, A
    Schmaljohann, J
    Staudenherz, A
    Dudczak, R
    Kletter, K
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2001, 16 (04) : 289 - 295
  • [6] FDG-PET and hepatocellular carcinoma
    Kashiwagi, T
    JOURNAL OF GASTROENTEROLOGY, 2004, 39 (10) : 1017 - 1018
  • [7] Multiparametric FDG-PET/MRI of Hepatocellular Carcinoma: Initial Experience
    Hectors, Stefanie J.
    Wagner, Mathilde
    Besa, Cecilia
    Huang, Wei
    Taouli, Bachir
    CONTRAST MEDIA & MOLECULAR IMAGING, 2018,
  • [8] FDG-PET in the initial staging of squamous cell oesophageal carcinoma
    Buchmann, I.
    Hansen, T.
    Brochhausen, C.
    Kneist, W.
    Oberholzer, K.
    Junginger, T.
    Schreckenberger, M.
    Bartenstein, P.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2006, 45 (06): : 235 - 241
  • [9] Dynamic FDG-PET in patients with esophageal carcinoma.
    Choi, CW
    Yang, WI
    Lee, JS
    Lim, SM
    Hong, SW
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (05) : 242P - 242P
  • [10] FDG-PET evaluation of vaginal carcinoma
    Lamoreaux, WT
    Grigsby, PW
    Dehdashti, F
    Zoberi, I
    Powell, MA
    Gibb, RK
    Rader, JS
    Mutch, DG
    Siegel, BA
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 62 (03): : 733 - 737
12345